Replies to post #487 on Merck and Co Inc (MRK)

[DewDiligence]

Would clinical trials that involve Amarin’s Vascepa and MRK’s drug compositions that include Keytruda or Zocor be “junk science”?

A combination with Zocor might make sense, but Zocor has been off-patent for several years, and MRK no longer has any interest in it.

A trial testing Vascepa in combination with Keytruda would indeed be junk science, in my humble opinion.